Neurological dysfunction following coronary artery bypass graft surgery Current enthusiasm for coronary artery bypass graft (CABG) surgery is well justified in terms of both the relief of angina, and prolongation of life expectancy in some subgroups of patients. Improvements in technique have resulted in a steady decline in the risks of the procedure and, in good centres, mortality rates below 2% are the rule. This combination of enthusiasm and decreasing risk has contributed to a continuing rise in the number of operations performed, associated with a tendency for CABG to be offered to patients with milder degrees of coronary artery disease.
Since the advent of open heart surgery, serious neurological morbidity has been recognized, and CABG surgery has not been spared. Recent studies from Newcastle upon Tyne', and from the Cleveland Clinic, Ohio2, have reported incidences of fatal cerebral injury of 0.3% and 0.7% respectively. The overall incidence of postoperative neurological morbidity reported in the Newcastle study was 61%. Many studies have shown lesser degrees of morbidity but all are open to criticisms of technique. Most are retrospective, with assessment performed by non-neurologically trained investigators and the timing of assessments being less than optimum. Many are merely retrospective reviews of case notes. These studies will detect overt morbidity such as major stroke but are of no value in defining more subtle neurological dysfunction.
What, then, is the true incidence of CABG-related neurological morbidity? From recent prospective studies a picture of the incidence and spectrum of neurological morbidity emerges. The Cleveland Clinic study2 included 418 patients, 30% of whom developed neurological complications. The Newcastle study included 312 patients with an incidence of 61%, as quoted above. This latter study included neuropsychological evaluation, demonstrating immediate postoperative impairment in 79%/ of patients tested3. The clinical spectrum of neurological disorders described affects all levels of the nervous system.
Disturbance of conscious level ranging from protracted somnolence to frank coma was found in 3%1l.
Postoperative coma is especially sinister, carrying a high probability of death or serious neurological sequelae4. Perioperative stroke was found in 4.8% 1 and 5.2%2 and resulted in permanent neurological disability in 1.3% and 2% respectively. Visual symptoms are common after CABG and detectable ophthalmological signs occurred in 25% in the Newcastle study, including retinal infarcts and emboli, visual field defects and unexplained reduction in visual acuity. Rarer central nervous system (CNS) complications reported in the literature include postoperative seizures and spinal cord infarction. Neurological signs detected in the absence of clinical disability include isolated extensor plantar responses, and the development of primitive reflexes. These latter clinical signs are of great interest and probably indicate that minor subclinical cerebral injury is very common.
Peripheral nervous system damage is not uncommon. Brachial plexus damage occurs in about 7% of patients'. Other peripheral complications include damage to the phrenic, ulnar, median, common peroneal, lateral femoral cutaneous, saphenous and facial nerves. Sympathetic damage resulting in Homer's syndrome may also occur.
The neuropsychological morbidity described in 30% of patients by Savageau et al. 6 and in 79% in the Newcastle study3 appears to result from cardiopulmonary bypass rather than a nonspecific effect of major surgery. Whilst there is evidence that this neuropsychological impairment commonly recovers satisfactorily within 6 months, the impact on patients' lives of early cognitive changes and of psychiatric disturbances after CABG may be greater than is generally appreciated. Impairment of new learning ability, psychomotor speed, concentration, and short-term memory are the most frequently detected cognitive changes. The clinical significance of this catalogue of neurological and neuropsychological morbidity should not be overestimated. Death or disabling stroke are infrequent and the potential benefit of CABG surgery to patients incapacitated by angina clearly outweighs the risk. Approximately 8% of patients in the Newcastle study had important neurological disability at the time of their discharge from hospital. However, lesser degrees of functionally significant damage are worrying to patients and their relatives. Experience suggests that these minor problems are usually undiagnosed on busy postsurgical wards. Much of this morbidity resolves rapidly, and severe neurological disability persisting at six months after surgery is infrequent.
In view of the incidence and natural history of this morbidity, what should preoperative patients and their relatives be told by their doctor about the risks of CABG? It would seem reasonable to advise the patient that minor transient disturbances of vision, memory and concentration are common in the postoperative period but may be expected to resolve. There is a much lesser risk of stroke occurring and the incidence of stroke with serious permanent disability is slight. From the point of view of doctors participating in the postoperative care, there is clearly no need for detailed neurological examination in every case to detect functionally insignificant signs. They should, however, be aware 0141-0768/86 030130-02/$02.00/0 0 1986 The Royal Society of Medicine of the variety of problems that their patients may encounter, and be prepared and informed in order to discuss these and to give reassurance regarding outcome. Postoperative coma and definite stroke remain indications for neurological consultation.
Currently there is no clear evidence in the literature regarding either the definition of preoperative predisposing factors to assist in patient selection, or of intraoperative or postoperative causative factors. The two major aetiological factors cited in the causation of neurological damage in heart surgery are hypoperfusion of the CNS, and embolization. Hypoperfusion may result from hypotension7, low flow8, loss of the pulsatile component of perfusion9 and, especially in CABG patients, arteriosclerotic cerebrovascular occlusive disease. Macroembolization may result from air'0, dislodgement of mural thrombus' or dislodgement of aortic atheroma". Microembolization may result from air'2, aggregates of platelets, white cells or fibrin'3"14, fat'5, silicone"6 or polyvinyl chloride tubing fragments'7.
It will be desirable to monitor future advances in cardiopulmonary bypass techniques using accurate neurological assessment. In addition, other, possibly more sensitive, markers of CNS damage should be studied. Biochemical markers of nerve cell injury such as adenylate kinase and brain-specific creatine kinase in the CSF are potentially useful here. The measurement of regional cerebral blood flow using xenon-133 single photon emission computerized tomography may also prove a valuable method for objectively assessing cerebral dysfunction.
The prediction of at-risk patients might be aided by digital subtraction angiography to visualize the degree and distribution of cerebrovascular atheroma prior to surgery. Treatment and prevention may be aided by the study of membrane versus bubble oxygenators, arterial line filters, platelet antiaggregants such as prostacyclin, and the effect of more accurate control of heparinization. Optimal thresholds of flow, pressure and pulsatility during bypass need to be defined more clearly. The possibility of pharmacological protection of the brain from ischaemic injury, using barbiturates or calcium blockers, should be explored.
Recent prospective studies have demonstrated that neurological damage is much more common after CABG than was previously supposed. These studies provide a valuable starting point for the evaluation of future attempts to improve cardiopulmonary bypass. The addition of modem neuroinvestigative techniques, biochemical estimations of markers of brain injury, and pharmacological manipulation to studies involving careful neurological assessment will improve our knowledge of the predisposing and causative factors for brain damage. P J Shaw Departme?kt ofNeurology Royal Victoria Infirmary, Newcastle-upon-Tyne
